The Conference Forum, a life science industry research firm that develops annual conferences primarily around how to get therapeutics to patients faster, has announced record growth in attendees and re-signs in 2024 across its portfolio of medicine development events.
“When you serve an extraordinary community of medicine developers and patient advocates, you have to raise the bar each year in creating high-end, engaging content and conference experiences," said Valerie Bowling, Executive Director and Co-Founder, the Conference Forum. "It is gratifying to see this pay off in record growth.”
The nine conferences in 2024 focused on:
- Patient centricity and involvement in clinical research from both the US and EU perspectives
- Innovation in clinical trial operations
- Digital technologies in clinical trials
- Business, academic and industry progress in immuno-oncology
- Integrating care and research
- R&D and Chief Medical Officer leadership
- Advancements and partnership opportunities in drug delivery
"When you serve an extraordinary community of medicine developers and patient advocates, you have to raise the bar each year in creating high-end, engaging content and conference experiences."
The 2024 events attracted representatives from 250 pharma and biotech companies across 28 countries, with a 20% increase in attendance over 2023. The conferences provided attendees with the opportunity to hear from leaders inside and outside the medicine development industry, and from advocates raising the voices and visibility of patients.
“Achieving a record number of attendees in 2024 and re-signs for 2025 is like receiving the best report card from the drug development and delivery industry.”
A small sample of some of the outstanding 2024 speakers included:
- Christina Brennan, MD, MBA, SVP, Clinical Research, Northwell Health
- Kathryn Capanna, MBA, Associate Office Director for Strategic Development, Office of Strategic Programs & Technology Innovation, FDA / CDRH
- Bill Cassidy, MD, US Senator for Louisiana
- Laura Esserman, MD, MBA, Director, Carol Franc Buck Breast Cancer Center, University of California, San Francisco
- Patrick Gee, Sr, PhD, JLC, Founder and Chief Executive Hope Dealer, iAdvocate, Inc
- Paul Hudson, CEO, Sanofi
- Robert Langer, PhD, David H. Koch Institute Professor, MIT
- Irisaida Mendez, Patient Advocate
- Michael Meyers, Vice Chairman and Head of M&A and Strategic Advisory Services, HC Wainwright & Co
- Karen Peterson, Founder and Chief Patient Advocate, Karen’s Club
- Gary Pisano, PhD, Harry E Figgie, Jr Professor of Business Administration, Harvard Business School
- Ambassador Chesley “Sully” Sullenberger, Captain, US Airways Flight 1549
- Sarah Zenner-Dolan, Patient Advocate
- Meredith Zozus, PhD, CCDM, Director, Clinical Research Informatics, UT Health San Antonio
“Achieving a record number of attendees in 2024 and re-signs for 2025 is like receiving the best report card from the drug development and delivery industry,” said Meredith Sands, Executive Director, Business Development, and Co-Founder, the Conference Forum.
To learn more about the upcoming conferences for 2025, visit theconferenceforum.org.
